Skip to content

Luchtbrug Junior: The next step

Luchtbrug Junior: The next step - Luchtbrug Junior: The next step

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56863
Enrollment
290
Registered
2024-07-04
Start date
2025-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preschool wheeze preschool wheeze

Interventions

Children with preschool wheeze in the intervention group (online care via Luchtbrug junior) will have scheduled visits to the outpatient clinic every 6 months after starting the study. Thus, in the

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Children aged 2 to 6 years with a doctor*s diagnosis of preschool wheeze - Children have an indication for regular follow-up of at least one year by a  paediatrician because of respiratory symptoms; - Children are treated with inhaler medication, including inhaled  corticosteroids;  - A history of at least one episode of wheezing within the last 12 months, assessed by a healthcare professional, either directly observed by the professional or reported by the patient’s parents/caregivers, or: - At least one hospital admissions due to pulmonary symptoms before inclusion.  - Informed consent of parents/caregivers

Exclusion criteria

Exclusion criteria: - Underlying chronic cardiopulmonary or neuromuscular condition, or known recurrent aspirations; - Underlying syndromes associated with pulmonary comorbidities; - Prematurity

Design outcomes

Primary

MeasureTime frame
The main study endpoint for this study is the number of symptom free days (SFD) within the last four weeks of the study (measured at T=12) as reported by parents/caregivers during the last study visit. SFDs will be based on the TRACK questionnaire.

Secondary

MeasureTime frame
Symptoms scores using the TRACK questionnaire Quality of life of caregivers Perceived therapy adherence Continuous medication adherence monitoring using smartinhalers Cost-effectiveness analysis Healthcare consumption Patient reported experiences measures (PREMs) Perceived self-management

Countries

Netherlands

Contacts

Public ContactM.C.L. Kleuskens

Radboud Universitair Medisch Centrum

mirese.kleuskens@radboudumc.nl024 316 68957

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026